Menu
Home
Uitgevers
Categorieën
Trending
Inbox
Account aanmaken
Aanmelden
English
Deutsch
Redefining biopharma innovation: Sanofi’s S$800m Modulus facility in Singapore
Edb.gov.sg
Abonneren
0
Klik hier om u te abonneren op Edb.gov.sg
Laden...
Afgelopen dinsdag om 08:00
Html
Tekst
#EDBWrapped2024: We’re ending 2024 with a recap of this year’s highlights!
View in browser here
.
#EDBWrapped2024:
EDB wishes all a delightful festive season and a Happy New Year! Here’s a recap of what you enjoyed reading in 2024
Check it out
Flexible, fast, and sustainable: How Sanofi is producing the next generation of vaccines and biopharma medicines
Read more
A US$263b opportunity: Three tech leaders say why Singapore is a gateway to SEA’s thriving digital economy
Get insights
Adding value and ‘not just costs’: Edwards LifeSciences’ Eric Monzon on Singapore’s MedTech ecosystem
Get insights
Febreze and Gorilla® Glass – Meet the MNCs making products for the world from Singapore
Learn more
Brought to you by
Singapore Economic Development Board
250 North Bridge Road
#28-00 Raffles City Tower
Singapore 179101
Connect with EDB
:
Scan QR code to connect on WeChat
You received this email because you signed up for regular updates on Asian business insights and news.
To contact us or unsubscribe, please use the links below.
Contact us
|
Update preferences
|
Unsubscribe
|
Privacy policy
|
Terms of use
Deel deze op
Laden...
Andere nieuwsbrieven van
Edb.gov.sg
Redefining biopharma innovation: Sanofi’s S$800m Modulus facility in Singapore
Edb.gov.sg
Afgelopen dinsdag om 08:00
MedTech’s Top 30 firms say why they’re manufacturing in Singapore
Edb.gov.sg
25 dagen geleden
EDB’s S$32m plan to drive corporate venturing
Edb.gov.sg
2 maanden geleden
Meer nieuwsbrieven van Edb.gov.sg
Laden...
Gerelateerde nieuwsbrieven
[[subject]]
[[publisher.name]]
[[date]]
© 2024
Algemene voorwaarden
Privacy
Sluit
Home
Uitgevers
Categorieën
Trending
Inbox
Account aanmaken
Aanmelden
© 2024
Algemene voorwaarden
Privacy
English
Deutsch